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ORIGINAL ARTICLE
Predicting long-term outcome of Internet-delivered cognitive
behavior therapy for social anxiety disorder using fMRI and
support vector machine learning
KNT Månsson1, A Frick2, C-J Boraxbekk3,4, AF Marquand5,6, SCR Williams6, P Carlbring7, G Andersson1,8 and T Furmark2
Cognitive behavior therapy (CBT) is an effective treatment for social anxiety disorder (SAD), but many patients do not respond
sufﬁciently and a substantial proportion relapse after treatment has ended. Predicting an individual’s long-term clinical response
therefore remains an important challenge. This study aimed at assessing neural predictors of long-term treatment outcome in
participants with SAD 1 year after completion of Internet-delivered CBT (iCBT). Twenty-six participants diagnosed with SAD
underwent iCBT including attention bias modiﬁcation for a total of 13 weeks. Support vector machines (SVMs), a supervised pattern
recognition method allowing predictions at the individual level, were trained to separate long-term treatment responders from
nonresponders based on blood oxygen level-dependent (BOLD) responses to self-referential criticism. The Clinical Global
Impression-Improvement scale was the main instrument to determine treatment response at the 1-year follow-up. Results showed
that the proportion of long-term responders was 52% (12/23). From multivariate BOLD responses in the dorsal anterior cingulate
cortex (dACC) together with the amygdala, we were able to predict long-term response rate of iCBT with an accuracy of 92%
(conﬁdence interval 95% 73.2–97.6). This activation pattern was, however, not predictive of improvement in the continuous
Liebowitz Social Anxiety Scale—Self-report version. Follow-up psychophysiological interaction analyses revealed that lower dACC–
amygdala coupling was associated with better long-term treatment response. Thus, BOLD response patterns in the fear-expressing
dACC–amygdala regions were highly predictive of long-term treatment outcome of iCBT, and the initial coupling between these
regions differentiated long-term responders from nonresponders. The SVM-neuroimaging approach could be of particular clinical
value as it allows for accurate prediction of treatment outcome at the level of the individual.
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INTRODUCTION
Social anxiety disorder (SAD) is a common1 and disabling disorder
that often precedes other serious mental health problems such as
depression.2 SAD is associated with aberrant information-
processing and cognitive biases toward negative information
regarding the self, for example, self-focused attention.3 Cognitive
behavior therapy (CBT), including modiﬁcation of cognitive biases,
is an effective treatment for SAD,4 and can be delivered in
accessible formats, for example, via the Internet.5 Internet-
delivered CBT (iCBT) has been evaluated in several randomized
controlled studies at different sites,5 and sustained effects have
been observed up to 5 years later.6 Also, CBT for SAD has been
shown to be equally effective when delivered via the Internet in
comparison with face-to-face group treatment.7 However, sig-
niﬁcant proportions of the treated patients relapse over time or do
not respond sufﬁciently.8 Accordingly, improving long-term
treatment outcome of CBT remains an important challenge, and
factors that reliably predict lasting therapeutic success need to be
identiﬁed.
Recent functional magnetic resonance imaging (fMRI) studies
suggest that neural biomarkers add substantial value to
predictions of CBT outcome. In SAD participants, Doehrmann
et al.9 demonstrated that initial activations of the visual cortex, in
response to emotional face stimuli, predicted symptom improve-
ment with CBT, and that brain measures vastly improved
prediction success in comparison with other clinical variables.
Klumpp et al.,10 using a similar task, found that pretreatment
reactivity in the inferior frontal and the superior and middle
temporal gyri was associated with reduced social anxiety
following CBT. However, both studies evaluated the short-term
treatment response only. In a previous positron emission
tomography study from our lab, the initial attenuation (pre–post)
of anxiety-related amygdala activity in treated SAD participants
was associated with clinical improvement 1 year later, but as the
sample was small the study could not discriminate properly
between the effects of CBT and selective serotonin reuptake
inhibitors (SSRIs).11
Mass-univariate voxel-wise methods, seeking pretreatment
brain voxels that correlate with symptom improvement or differ
between responders and nonresponders, have so far been the
most common approach in psychiatric prediction studies. How-
ever, such studies may not be easily translated to clinical settings
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when the concern is whether or not a certain patient will respond
to a speciﬁc treatment. In contrast, supervised pattern recognition
methods constitute a novel approach in clinical neuroimaging,
utilizing patterns of information across many voxels, for example,
to separate responders from nonresponders.12 In pattern recogni-
tion, a statistical model is estimated on a subset of the data
(‘training’) and then applied to predict the diagnostic or
prognostic label of novel unseen data (‘testing’). This is usually
achieved within a cross-validation procedure, whereby the model
is repeatedly retrained, withholding a different partition of data
each time. This approach is standard within the statistical
literature and is well known to provide approximately unbiased
estimates of generalizability to new samples, and helps to
minimize the possibility of ‘over-ﬁtting’ the data. Of crucial
importance, and in contrast to voxel-wise group statistics, pattern
recognition analyses can make predictions at the level of the
individual based on the pattern within the data, for example,
treatment responder status or diagnostic category for a new
unseen participant.12,13
A supervised pattern recognition method called support vector
machine (SVM)13 was recently successful in separating SAD from
panic disorder participants, and from healthy controls.14 In
addition, we recently demonstrated the utility of SVM and
accurately discriminated SAD participants from healthy controls
based on the multivariate pattern of blood oxygen level-
dependent (BOLD) response in the fear network,15 that is, the
amygdala, hippocampus, anterior cingulate cortex (ACC) and
insula, frequently demonstrated to be dysfunctional in SAD.16
Pretreatment reactivity in fear network regions has also been
associated with subsequent treatment outcome in SAD and other
anxiety disorders.17,18 The ACC in particular has been implicated in
treatment prediction studies of depression,19 and anxiety.20
Moreover, cognitive control of emotion, involving prefrontal–
limbic interactions,21 has been suggested to be impaired in
participants with SAD and restored with CBT22 but it is not known
whether such interactions are predictive of treatment response in
SAD. Although the SVM approach has been successful in
predicting treatment response in depression,23 there are, to our
knowledge, no studies using SVM to predict CBT treatment
outcome in anxiety disorders such as SAD. Also, neuroimaging
prediction studies of long-term treatment effects are largely
lacking in psychiatric research.24
The objective of the present study was to use SVM classiﬁcation
to evaluate neural predictors of long-term iCBT response 1 year
after treatment of participants with SAD. In addition to iCBT, the
participants underwent Internet-delivered attention bias modiﬁca-
tion (ABM) in a cross-over design.25 Adding ABM has not been
shown to further improve outcome,26 and we refer to the present
combined intervention as iCBT. Using a disorder-relevant fMRI
paradigm, we entered BOLD responses to sentences with negative
content about oneself, that is, self-referential criticism27 into linear
SVMs to classify responder status at long-term follow-up. Our SVM
analyses focused primarily on the fear network and brain regions
associated with cognitive control of negative emotion, that is, the
ACC, amygdala, hippocampus, insula, ventromedial prefrontal
cortex and dorsolateral prefrontal cortex.
MATERIALS AND METHODS
Participants
This study included 26 right-handed participants with a primary diagnosis
of SAD (85% having the generalized subtype, recruited via media
advertisements (see Table 1 and Supplementary Figure S1 in
Supplementary Material). The sample, including inclusion/exclusion
criteria, has been described in detail elsewhere,25 and the screening
procedure was similar to our previous treatment studies.5,28 Brieﬂy,
participants reported interest on a webpage and answered self-report
questionnaires via the Internet regarding social anxiety, depression and
magnetic resonance safety. Participants had no neurological or major
somatic disorder, no suicidal ideation, no other ongoing psychological
treatment and they were not included if psychotropic medication (for
example, SSRIs) was recently initiated or changed, that is, a stable dose for
3 months was required. Applicants fulﬁlling the initial screening criteria
were interviewed via telephone using the structured clinical interview for
the 4th version of Diagnostic and Statistical Manual of Mental Disorders
(DSM-IV) axis 1 (SCID-I).29 At baseline, 8 (31%, 8/26) participants were
currently on prescription medication, that is, SSRIs. Five participants had a
history of SSRI treatment and 13 were medication-naive. One participant
(deemed as nonresponder) increased the dose from 50–100mg sertraline
from posttreatment to 1-year follow-up. Three participants withdrew and
did not take part in the 1-year follow-up.
All participants gave written informed consent prior to participation. The
study was conducted in accordance with the Declaration of Helsinki and
approval was obtained from the regional ethic committee. The study was
registered at ClinicalTrials.gov (ID: NCT01312571).
Assessment of clinical response
Treatment response at 1-year follow-up was assessed with the Clinical
Global Impression-Improvement (CGI-I) interview scale.30 In accordance
with prior studies,30 scores of 1 or 2 (very much or much improved)
deﬁned treatment responders, whereas participants scoring ⩾ 3 (ranging
from minimally improved to very much worse) were classiﬁed as
Table 1. Demographic and clinical characteristics of study participants
All participants
(n= 26)
Responders at 1 year
(n= 12)
Nonresponders at 1 year
(n= 11)
Responders vs nonresponders at 1
year (n= 12/11)
Age (years), mean (s.d.) 32.3 (9.6) 35.5 (8.5) 31.5 (10.3) t(21)= 1.01, P = 0.837
Range (years) 19–57 21–47 20–57
Gender, female (%) 22 (85) 9 (75) 10 (91) χ2(1)= 1.01, P= 0.315
Married or de facto, n (%) 15 (58) 7 (58) 7 (64) χ2(1)= 0.07, P= 0.795
Educational level, n (%) Fisher's exact P= 0.386
Completed university 9 (35) 5 (42) 3 (27)
Current university 10 (38) 5 (42) 3 (27)
Lower gradea 7 (27) 2 (17) 5 (45)
Psychotropic medication, n (%) 8 (31) 3 (25) 4 (36) χ2(1)= 0.35, P= 0.554
Age of SAD onset (years),
mean (s.d.)
15.9 (6.0) 16.3 (4.2) 16.6 (7.7) t(21)= 0.12, P = 0.907
Pretreatment LSAS-SR, mean
(s.d.)
76.3 (18.7) 74.1 (15.1) 77.6 (23.9) t(21)= 0.43, P = 0.672
Pretreatment MADRS-S, mean
(s.d.)
15.8 (6.6) 15.4 (8.1) 15.4 (5.8) t(21)=− 0.02, P= 0.986
Abbreviations: LSAS-SR, Liebowitz Social Anxiety Scale—Self-report; MADRS-S, Montgomery Åsberg Depression Rating Scale—Self-report; SAD, social anxiety
disorder. aIncluding high school, vocational school and compulsory school.
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nonresponders. Two psychologists, blind to the experimental conditions,
conducted the interviews. In addition, we predicted long-term clinical
improvement (pre follow-up) using the continuous Liebowitz Social
Anxiety Scale—Self-report version, LSAS-SR.31
Treatment
This study included two forms of intervention for SAD. Both treatments
were provided to all participants in a cross-over design where half of the
participants started with iCBT and the other half started with ABM.25 The
guided iCBT protocol contained a 9-week intervention supported by a
clinician and has been found effective in several randomized controlled
trials.5,28,32,33 Previously, we showed that the short-term outcome in this
sample was in favor of iCBT, that is, 66% of the iCBT participants, in
comparison with 25% of the ABM group, were deemed as CGI-I
responders.25 At the 1-year follow-up, we found no effect of the order
(χ2 = 0.4, P= 0.51) in which the two interventions were presented.
Brieﬂy, the treatment program is based upon the cognitive model of
SAD described by Clark and Wells.3 The self-help text included information,
exercises, homework assignments and ended with essay questions that
were sent to the therapist. For more details, see Andersson et al.5 and
Supplementary Material. The second intervention was ABM delivered over
4 weeks via the Internet, with exercises implemented twice a week,
totaling eight sessions. ABM aims at changing the distorted attentional
process characterizing anxiety disorders, that is, hypervigilance, or problem
of disengagement from fearful stimuli.34 The Internet-delivered ABM used
in this study was a web-based ﬂash program displayed in full-screen mode
at the participant’s computer. E-mail and mobile phone SMS reminders
prompted for each training session, scheduled on Tuesdays and Thursdays
over the 4-week treatment course. The participant and therapist had no
other communication during the treatment period.
Experimental task
We evaluated BOLD responses to self-referential criticism using a disorder-
relevant paradigm developed by Blair et al.,27 which was translated into
Swedish. The sentences were split into three categories based on the
referential target: self, other female or other male. The task included 216
sentences divided into three categories based on valence: negative (for
example, ‘Nobody likes you’), neutral (for example, ‘You read’) or positive
(for example, ‘Everyone loves you’) valences. Across valences, sentences
were matched on number of letters and words, and appeared in
randomized order. Participants were instructed to read the sentences
and press a button with the right hand when they had read each sentence.
Each sentence was presented for a maximum of 2500ms. In addition, 96
ﬁxation crosses (‘+’) were randomly interspersed between the sentences
and displayed for 2500ms. Each sentence and ﬁxation cross was separated
by a cross or circle presented for 500ms. Stimuli were demonstrated using
the E-prime 2.0 software (Psychology Software Tools, Pittsburgh, PA, USA),
projected on a screen and viewed through a tilted mirror attached to the
head coil. The total duration of the task was 17min and 20 s.
Imaging
Structural and functional image acquisition. Structural high-resolution T1-
weighted images (180 slices, 1 mm thickness, ﬁeld of view: 250mm, voxel
size: 0.5× 0.5× 1mm3) were collected prior to the functional images. BOLD
contrast images (T2* weighted) were acquired using a 3T Discovery MR750
(General Electric, Madison, WI, USA) scanner equipped with a 32-channel
head coil. The following scanning parameters were used: echo time: 30ms,
repetition time: 2000ms, ﬂip-angle: 80°, ﬁeld of view: 25× 25 cm2, matrix
size: 96 ×96. Thirty-seven slices with a thickness of 3.4mm (2.6 × 2.6× 3.4
voxel size) were acquired every 2000ms. Ten dummy scans were run before
the image acquisition started to avoid signals resulting from progressive
saturation. Preprocessing was done using Statistical Parametric Mapping
Software 8 (SPM8; Wellcome Department of Cognitive Neurology, London,
UK) implemented in MATLAB (Mathworks, Natick, MA, USA). Functional
scans were realigned to the mean image of each run to correct for head
movements during image acquisition, after which slice timing correction
was performed. The functional scans (3 × 3× 3mm3 voxel dimensions) were
then co-registered to the structural scans. Structural scans were segmented
into gray and white matter, and parameters for warping the scans to the
Montreal Neurological Institute (MNI152) template were calculated using
the uniﬁed segmentation procedure in SPM8. Functional scans were
subsequently warped to MNI standard space by applying these parameters,
and smoothed with an 8-mm isotropic Gaussian kernel.
Data analysis
Functional brain imaging data were ﬁtted to the general linear model
using SPM8. First-level, within-subject, analyses included nine regressors of
interest in the model, valence (3) × target (3), containing onset times of
respective sentences, as well as the isx movement parameters from the
realignment preprocessing step as nuisance regressors. The model was
convolved with the canonical hemodynamic response function deﬁned in
SPM8 and ﬁltered using a 128-s high-pass ﬁlter. The other-referred contrast
consisted of both female and male targets, and the contrast of interest
used in subsequent analyses was self-referential criticism (self-negative
minus other negative). On the basis of previous CBT prediction
studies,11,17,18 we selected fear network regions of interest (ROIs) including
the ACC, amygdala, hippocampus and insula. All regions were deﬁned by
the Automatic Anatomical Labeling ROI library within the Wake Forest
University PickAtlas software.35 In follow-up analyses, the ACC was
divided into the dorsal (dACC) and ventral (vACC) subdivisions by a split
at the MNI-coordinate z=8, which corresponds to clusters 2 and 3 in
Beckmann et al.36
We also investigated the predictive value of regions involved in
cognitive control of negative emotion,37 including the dorsolateral
prefrontal cortex (Brodmann areas 9 and 46) and ventromedial prefrontal
cortex (10 mm radius spherical ROI centered at [x,y,z] = [4,32,− 5]).38
Behavioral treatment effects and initial responder/nonresponder differ-
ences on demographic and clinical data were calculated using the STATA
statistical software, v. 13.1 (Stata, College Station, TX, USA).
Support vector machine learning
SVM analyses were carried out using the Pattern Recognition for
Neuroimaging Toolbox.39 For each ROI or network, pretreatment contrast
images of self-referential criticism were summarized using a dot-product
kernel matrix, which was then used as input to a linear SVM. Each SVM was
embedded within a leave-one-participant-out cross-validation framework
and for each cross-validation fold, data were centered using the mean of
the training data. The SVM soft margin parameter C was ﬁxed to its default
value 1.39 SVMs were trained to separate CGI-I responders from
nonresponders at 1-year follow-up. We employed SVMs because they
provide excellent performance for neuroimaging data relative to
alternative approaches such as random forests.40 We tested the statistical
signiﬁcance of each classiﬁer using permutation testing. This involved
repeating the cross-validation procedure (1000 times) after randomly
permuting the class labels. Signiﬁcance of the classiﬁcation accuracy was
then derived by counting the number of times the permuted accuracy
exceeded the true accuracy and dividing by 1000.
We used a discriminative mapping approach to visualize the relative
contribution of the different brain regions to the classiﬁer decision. This is a
standard approach in SVM studies using neuroimaging data39 and was
achieved by mapping the predictive weights in the original voxel space. It
is important to emphasize that the voxel weights should not be
interpreted as describing focal differences between classes in the same
way as in mass-univariate analysis. Instead, the weights should be
interpreted as a multivariate pattern, where the weight indicates the
direction and quantiﬁes the contribution of each voxel to the classiﬁer
decision. They do not permit inference at the level of individual voxels.
As a complement to SVM analyses on the dichotomous CGI-I measure,
we also conducted relevance vector regressions41 in Pattern Recognition
for Neuroimaging Toolbox with the aim to predict improvement (pre
follow-up) on the continuous LSAS-SR.
In the main analyses we found the ACC to be highly predictive of long-
term response. Because the ACC has strong anatomical connection with
the amygdala,42 and because it is a functionally heterogeneous region, for
example, with regard to control and expression of negative emotion,43 we
analyzed the dACC and vACC subregions separately, and together with
the amygdala. Furthermore, follow-up analyses (guided by the signiﬁcant
SVM classiﬁcations) using mass-univariate voxel-wise comparisons
of initial BOLD response to self-referential criticism were performed
between responders and nonresponders, and psychophysiological
interactions44 were conducted using the dACC and vACC as seeds to
evaluate couplings between these regions and the amygdala during self-
referential criticism.
Supplementary analyses
Additional SVM analyses were performed using an intention-to-treat
approach, that is, all participants that withdrew from the study were
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deemed as nonresponders. We also excluded all participants with
concurrent psychotropic medication. In addition, ROIs from two previously
reported univariate prediction studies of short-term outcome of CBT for
SAD9,10 were evaluated, as well as whole-brain analysis. SVM prediction of
SAD diagnostic status, assessed with the structured clinical interview for
DSM-IV,29 was also performed. In addition, we checked for associations
between descriptive variables (Table 1) and responder status, withdrawal
and treatment compliance. Furthermore, the predictive value of descrip-
tive (clinical and demographic) variables on long-term clinical response
was assessed by multiple logistic regression analyses. Results of these
analyses are reported in Supplementary Material.
RESULTS
Prediction of long-term clinical response
There were 12/23 (52%) responders at 1-year follow-up according
to the clinical interview CGI-I. Participants improved on the LSAS-
SR from pretreatment to follow-up (t(23) = 7.52, Po0.001, mean
75.37 ± 19.1 to 44.67 ± 22.8), and there was no signiﬁcant change
between the posttreatment and 1-year follow-up assessments (t
(23) = 0.70, P= 0.489).25
SVM analyses of pretreatment BOLD response to self-referential
criticism (self4other referred criticism) showed that information
from the ACC was highly accurate in classifying CGI-I responder
status 1 year after treatment (balanced accuracy 91.7%, con-
ﬁdence interval 95% 73.2–97.6; Table 2 and Figure 1). Relevance
vector regression predictions of improvement on the LSAS-SR
were not signiﬁcant (P40.100).
SVM analyses taking ACC subdivisions into account showed that
the dACC alone (balanced accuracy 86.7%, conﬁdence interval
95% 67.9–95.5, P= 0.001, area under the receiver-operating
characteristic curve (AUC) = 0.97) and dACC together with the
amygdala (balanced accuracy 91.7%, conﬁdence interval 95%
73.2–97.6, P= 0.001, AUC= 0.89), but not the vACC, predicted 1-
year treatment response. Furthermore, psychophysiological inter-
action analyses showed that the dACC, but not the vACC, was
signiﬁcantly (family-wise error, FWE corrected) less coupled with
the right amygdala during self-referential criticism at pretreatment
(Z= 2.91, PFWE = 0.036, 729mm3, x,y,z [30,− 1,− 14], see also
Figure 2) in long-term responders relative to nonresponders, with
a similar tendency for dACC–left amygdala coupling (Z= 1.81,
Puncorrected = 0.035, 54 mm3, x,y,z [− 21,− 1,− 11]). Also, pretreat-
ment voxel-wise univariate analyses suggested that the dACC was
less reactive to self-referential criticism in responders as compared
with nonresponders, although this was signiﬁcant only when
participants on concurrent medication were excluded from the
analysis (Z= 3.48, PFWE = 0.030, 4320mm3, x,y,z [12,32,28]).
Supplementary analyses
Consistent with the main results, supplementary SVM analyses
using the intention-to-treat approach revealed accurate prediction
of 1-year iCBT responder status based on information from the
ACC, and this region also remained a signiﬁcant predictor when
participants on concurrent psychotropic medication were
excluded (Supplementary Material). Neither whole-brain nor ROI
analyses using brain regions implicated in previous univariate
SAD-fMRI prediction studies of CBT outcome9,10 were predictive of
long-term response, and diagnostic status, according to the
structured clinical interview for DSM-IV, could not be predicted.
Descriptive characteristics in Table 1 and scanner movement
parameters did not differ between responders and nonresponders
at pretreatment. Also, multiple logistic regressions using clinical
and demographic variables did not reveal signiﬁcant associations
with long-term response to iCBT (see Supplementary Material).
DISCUSSION
By use of fMRI and SVM classiﬁcation, we demonstrate that initial
multivariate patterns of BOLD response to self-referential criticism
in the ACC accurately predicted long-term response to iCBT.
Further analyses showed that particularly the dorsal part of the
ACC, together with the amygdala, predicted 1-year responder
status, and that the initial coupling between these regions, as
measured by psychophysiological interactions, was signiﬁcantly
lower in responders relative to nonresponders.
Thus, in individuals with SAD, treatment response 1 year after
iCBT was accurately predicted by initial multi-voxel patterns of
BOLD response to self-referential criticism in the ACC (92%
balanced accuracy, deﬁned as the mean of sensitivity and
speciﬁcity). Our results are consistent with the notion that ACC-
dependent self-referential processing is relevant for treatment
outcome.45 Our long-term ACC ﬁndings are also coherent with
prior studies using mass-univariate approaches or SVM to predict
short-term response to CBT for SAD,10 panic disorder17 and
depression.18,19,45 The ACC is, however, a functionally hetero-
geneous region linked to diverse processes such as conﬂict
monitoring,46 action-outcome evaluation,47 fear expression48 and
emotion regulation.43 Future studies are needed to determine
whether such processes are involved in the current experimental
task.27 Meanwhile, reﬁned analyses in this study revealed that the
dACC, in contrast to the vACC, was highly predictive, both by itself
and together with the amygdala (92% balanced accuracy). Also,
voxel-wise univariate analyses suggested lower initial dACC–
amygdala coupling, and arguably also lower initial dACC reactivity
to self-referential criticism, in responders relative to nonrespon-
ders. Both the dACC and the amygdala have been associated with
fear expression.43,48,49 For instance, Vogt et al.50 examined the
whole cingulate cortex and showed that 60% of the fear-induced
activity was located in the dorsal ACC subregion, suggesting that
multivariate brain activation patterns particularly in fear-
expressing regions may inﬂuence sustained success of CBT.
Prior studies using clinical predictors of treatment response,
such as symptom severity, have reported mixed results in SAD.51
The supplementary analyses in the present study showed that
clinical and demographic variables, in contrast to SVM-fMRI, failed
to predict iCBT long-term outcome, consistent with the notion
that neuroimaging biomarkers add substantially to the predictive
value of conventional factors for clinical treatment response.9 This
was also noted in an fMRI random forest study on CBT outcome
predictors in generalized anxiety disorder and panic disorder.52
The clinical utility of the multivariate SVM method may be
substantial as it can predict accurately at the individual level. An
important feature is that this method provides approximately
unbiased estimates of generalizability to new cases. This was
achieved by training the models on one sample and testing them
Table 2. Predictions of clinical outcome at 1-year follow-up. The
sensitivity, speciﬁcity and balanced classiﬁcation accuracy (arithmetic
mean of sensitivity and speciﬁcity) are presented as percentages
Balanced
accuracy
P (balanced)a Sensitivity Speciﬁcity AUC
ACC 91.7 0.001 83.3 100.0 0.91
Amygdala 47.7 0.531 50.0 45.5 0.46
dlPFC 43.2 0.638 50.0 36.4 0.46
Hippocampus 51.9 0.412 58.3 45.5 0.37
Insula 43.6 0.592 41.7 45.5 0.45
vmPFC 39.0 0.694 41.7 36.4 0.29
Abbreviations: ACC, anterior cingulate cortex; AUC, area under the
receiver-operating characteristic curve; dlPFC, dorsolateral prefrontal
cortex; vmPFC, ventromedial prefrontal cortex. aP-values are calculated
from permutation testing with 1000 permutations. Signiﬁcant balanced
accuracies are in bold.
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on another independent sample, here realized using leave-one-out
cross-validation. This represents a ﬁrst step toward personalized
treatment where therapeutic choice is guided by neuroimaging
biomarkers. An important next step toward this objective is to
validate the SVM models derived here using larger data sets,
preferably derived from different sites and/or scanners.
There are several limitations of this study. Because of the small
sample size, the results should be interpreted with some caution
even though our sample size is in the higher range in comparison
with other neuroimaging treatment prediction studies in the
anxiety disorders.20 Unfortunately, reliability assessment of the
CGI-I was not performed although the long-term clinical outcome
is comparable to previous large-scale randomized controlled trials
of iCBT for SAD (including 1-year follow-ups).5,28 In contrast to the
CGI-I, we were not able to predict improvement on the LSAS-SR
continuous outcome and prediction of SAD diagnostic status,
using the structured clinical interview for DSM-IV, was also not
signiﬁcant, suggesting that treatment outcome measures should
be carefully selected in SVM prediction studies. The dACC–
amygdala activity may be predictive of change in global
symptoms rather than speciﬁc social anxiety symptoms, although
other reasons for the discrepancy should be noted, such as the
use of categorical vs continuous measures, and SVM vs relevance
vector regression machine-learning algorithms. Only 13
participants were treatment-naive at the ﬁrst fMRI assessment,
and possible drug × iCBT interactions cannot be ruled out entirely.
However, the distribution of participants on concurrent psycho-
tropic medication was not different between responders and
nonresponders and, importantly, the accurate predictions from
the ACC remained signiﬁcant when participants on concurrent
SSRI treatment were excluded from the main SVM analyses (see
Supplementary Material). Also, the supplementary intention-to-
treat approach yielded consistent signiﬁcant predictions by the
ACC. The generalizability of the present study, however, may be
limited because the SVM classiﬁcation algorithm has not been
applied to a separate clinical sample and our results may also be
speciﬁc for iCBT and/or the speciﬁc fMRI task. Thus, future SVM
research should investigate the predictive power of different
experimental tasks, including resting-state fMRI, on CBT delivered
both via the Internet and face-to-face.
In conclusion, we demonstrate that the initial dACC–amygdala
BOLD response pattern to self-referential criticism is predictive of
long-term treatment response to iCBT, and that lower pretreat-
ment coupling between these fear-expressing brain regions is
associated with stable symptom improvement. In contrast, clinical
or demographic variables were not associated with sustained
treatment response, underscoring the importance of taking into
account neuroimaging biomarkers in prediction studies. To our
Figure 1. Support vector machine classiﬁcation of responder status at 1-year follow-up in the anterior cingulate cortex. (a) Weight map
indicating relative weights ascribed to voxels at representative sagittal slices. (b) Classiﬁcation of responder status. (c) Receiver-operating
characteristic curve, including area under the curve (AUC= 0.91).
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knowledge, this is the ﬁrst study using the multivariate SVM–fMRI
method to successfully predict long-term treatment response in
an anxiety disorder. Although SVMs hold high promise, additional
studies involving the integration of imaging and related data from
more than one site will allow us to further evaluate the clinical
utility of this approach.
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